PASITHEA THERAPEUTICS CORP
KTTA·70261F202·US·Common Stock·Healthcare - Biotechnology-13D/G
KTTA (PASITHEA THERAPEUTICS CORP) is held by 12 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($1.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.6M), AMERIPRISE FINANCIAL INC ($1M). Net institutional sentiment: Mixed.
12
Holders
Avg rating(1 Elite)
$4.4M
Total Value
46% (16)
Fund Consensus
6 buying - 7 selling
Who's Trading
ActivistCOCoastlands Capital LP11.5%Jul 1, 2026
ActivistSTStonepine Capital Management, LLC5.8%Jun 23, 2026
InsiderCLCoastlands Capital LPBuy $53KJun 17, 2026
ActivistFUFunicular Funds, LP7.4%Apr 22, 2026
ActivistOPOpaleye Management Inc.10.0%Apr 8, 2026
ActivistCOCoastlands Capital LP10.0%Feb 27, 2026
InsiderSLSTEINMAN LAWRENCEBuy $100KNov 28, 2025
InsiderMTMarques TiagoBuy $25KNov 28, 2025
InsiderDSDumesnil SimonBuy $25KNov 28, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer